Nicotine Transdermal System 21 mg/24h

Nicotine Transdermal System 21 mg/24h patches for smoking cessation. Extended-release nicotine delivery for gradual withdrawal. Helps manage cravings and withdrawal symptoms.

The Nicotine Transdermal System 21 mg/24h is designed to aid in smoking cessation by delivering nicotine transdermally. This extended-release patch helps reduce cravings and withdrawal symptoms, supporting individuals in their efforts to quit smoking. It is typically used as part of a comprehensive smoking cessation plan.

Common effects of the Nicotine Transdermal System may include skin irritation at the application site. Some users may experience mild headaches, dizziness, or sleep disturbances. These effects are generally temporary and should subside as the body adjusts to the nicotine delivery.

Handle the Nicotine Transdermal System patches with care, ensuring they are applied to clean, dry skin. Avoid exposing the patch to high temperatures or direct sunlight. Always follow the instructions provided with the product to ensure safe and effective use.

The Nicotine Transdermal System may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to consult a healthcare provider before using this product if you are taking other medications. Additionally, avoid using this product with other nicotine-containing products to prevent excessive nicotine intake.